Sequential chemotherapy with cisplatin/gemcitabine (CG) followed by mitoxantrone/methotrexate/mitomycin (MMM) in patients with malignant pleural mesothelioma: A multicenter Italian Phase II Study (SITMP1)
- 31 May 2006
- journal article
- research article
- Published by Elsevier in Lung Cancer
- Vol. 52 (2) , 199-206
- https://doi.org/10.1016/j.lungcan.2006.01.002
Abstract
No abstract availableKeywords
This publication has 33 references indexed in Scilit:
- Chemotherapy options and new advances in malignant pleural mesotheliomaAnnals of Oncology, 2005
- Malignant mesothelioma in Italy, 1997American Journal of Industrial Medicine, 2003
- Analysis of survival of mesothelioma cases in the Italian register (ReNaM)European Journal Of Cancer, 2003
- Chemotherapy for malignant pleural mesothelioma: past results and recent developmentsBritish Journal of Cancer, 2003
- A multicentre phase II study of cisplatin and gemcitabine for malignant mesotheliomaBritish Journal of Cancer, 2002
- Multicentre phase II study of gemcitabine and cisplatin in malignant pleural mesotheliomaBritish Journal of Cancer, 2002
- The European mesothelioma epidemicBritish Journal of Cancer, 1999
- Cisplatin and Gemcitabine Treatment for Malignant Mesothelioma: A Phase II StudyJournal of Clinical Oncology, 1999
- Lung asbestos fiber content and mesothelioma cell type, site, and survivalCancer, 1991
- Survival patterns for malignant mesothelioma: The seer experienceInternational Journal of Cancer, 1988